Innovacell Secures Approval for IPO on Tokyo Stock Exchange in 2026 Innovacell, a firm specializing in cell therapy, has received IPO approval for its shares on the Tokyo Stock Exchange, set for early 2026.

Innovacell Secures Approval for IPO on Tokyo Stock Exchange in 2026 #Japan #Tokyo #Innovacell #Hifumi #Rheaos

Innovacell Closes Successful Series D Funding Round Raising Over 7.3 Billion Yen Innovacell has successfully completed its Series D funding round, raising over 7.3 billion yen, doubling its initial target and engaging various strategic investors.

Innovacell Closes Successful Series D Funding Round Raising Over 7.3 Billion Yen #Japan #regenerative_medicine #Shinagawa #Series_D #Innovacell

Innovacell Secures Approximately 400 Million Yen from Reos Capital Works for Innovative Cell Therapy Innovacell, a company focused on cell therapy for incontinence treatments, has successfully raised around 400 million yen through Reos Capital Works' fund.

Innovacell Secures Approximately 400 Million Yen from Reos Capital Works for Innovative Cell Therapy #Japan #Tokyo #Innovacell #Reos_Capital #ICEF15